<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>COVID-19 Vaccines | Handel Research Group</title>
    <link>https://handelgroup.uga.edu/tag/covid-19-vaccines/</link>
      <atom:link href="https://handelgroup.uga.edu/tag/covid-19-vaccines/index.xml" rel="self" type="application/rss+xml" />
    <description>COVID-19 Vaccines</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â©  Andreas Handel 2021 - information on this site does not reflect opinions of the University of Georgia</copyright><lastBuildDate>Fri, 01 Jan 2021 00:00:00 -0500</lastBuildDate>
    <image>
      <url>https://handelgroup.uga.edu/media/logo_hu5b753f44bbcc83398b978a15c08b2b08_90381_300x300_fit_lanczos_3.png</url>
      <title>COVID-19 Vaccines</title>
      <link>https://handelgroup.uga.edu/tag/covid-19-vaccines/</link>
    </image>
    
    <item>
      <title>Indirect Benefits Are a Crucial Consideration When Evaluating SARS-CoV-2 Vaccine Candidates</title>
      <link>https://handelgroup.uga.edu/publication/2021-gallagher-natmed/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 -0500</pubDate>
      <guid>https://handelgroup.uga.edu/publication/2021-gallagher-natmed/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
